Variable sensitivity of FLT3 activation loop mutations to the small molecule tyrosine kinase inhibitor MLN518
Jennifer Clark(Boston Children's Hospital), D. Gary Gilliland(Brigham and Women's Hospital)
Cited by 80
Related Papers
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
Drug therapy for acute myeloid leukemia
|Blood|2005|670
The OTT-MAL fusion oncogene activates RBPJ-mediated transcription and induces acute megakaryoblastic leukemia in a knockin mouse model
|Journal of Clinical Investigation|2009|110
Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus.
|The Journal of Clinical Endocrinology & Metabolism|1994|84
Stable expression of small interfering RNA sensitizes TEL-PDGFβR to inhibition with imatinib or rapamycin
|Journal of Clinical Investigation|2004|58